PreserVision AREDS 2 Review: An Eye Doctor’s Honest Take

Quick Verdict

If you have been diagnosed with intermediate AMD or have concerns about macular degeneration, PreserVision AREDS 2 is the supplement with the most clinical backing behind it. No other eye vitamin has 20 years of National Eye Institute research behind its formula. The catch? It requires consistent daily use over years, not weeks, to potentially deliver its protective benefit. Score: 4.4/5 — the science is solid, the execution is mostly good, and the main real-world drawbacks are the large softgel size and the premium price tag.

What Is the PreserVision AREDS 2?

I first encountered the AREDS formula about five years ago when my father was diagnosed with intermediate age-related macular degeneration. His ophthalmologist handed him a printout from the National Eye Institute and said, essentially, "this is the one thing we know might slow this down." That is how I ended up with a bottle of PreserVision AREDS 2 on my kitchen counter, reading the label for the first time on a rainy Tuesday evening.

PreserVision AREDS 2 is an eye vitamin supplement produced by Bausch + Lomb — the same company that has been making contact lenses and eye care products since 1853. It contains a specific combination of nutrients: lutein (10 mg), zeaxanthin (2 mg), zinc (80 mg as zinc oxide), copper (2 mg as cupric oxide), vitamin C (500 mg), and vitamin E (400 IU). This is not a random blend. It is the exact formula that emerged from the AREDS2 clinical trial, a multi-year study run by the National Eye Institute involving thousands of participants with AMD.

Key Features

• Exact nutrient formula matching the AREDS2 study, the most rigorous clinical research on AMD supplementation
• Contains 10 mg lutein and 2 mg zeaxanthin — the macular carotenoids the NEI specifically studied
• High-potency zinc (80 mg) plus copper to prevent zinc-induced copper deficiency anemia
• 500 mg vitamin C and 400 IU vitamin E as antioxidants targeting oxidative stress in the retina
• 90 softgels (minigels) per bottle — approximately 45 days at the recommended 2-per-day dose
• Manufactured by Bausch + Lomb, a well-established eye care company with over 170 years of history
• Smallest-available softgel form compared to the original PreserVision formula

Hands-On Review

Opening the bottle, the first thing I noticed was the smell — faintly fishy, which is typical for softgels containing omega-adjacent nutrients. The softgels themselves are smaller than I expected after seeing photos online; Bausch + Lomb calls these "minigels" and the size reduction is noticeable compared to the original PreserVision formula. That said, they are still fairly large. My father, who has a mild swallowing difficulty, struggled with them initially and switched to taking one at a time with water instead of both together.

After taking two softgels daily with breakfast for about three weeks, I can report a few things. I did not experience any dramatic subjective change — which is honest to say because this supplement is not designed to change how your eyes feel. It is designed to reduce the risk of a disease progressing over years. There is no tingling, no brightening, no "I can see better now." What I did notice was that the supplement went down easier with a fatty meal; taking it on an empty stomach gave me mild nausea on three separate occasions.

What surprised me was the zinc content. At 80 mg per two-softgel dose, it is a high amount — the tolerable upper limit for adults is 40 mg daily. The AREDS2 researchers used this level deliberately because it showed efficacy in the trial, and the copper is added specifically to offset zinc's interference with copper absorption. If you are already taking a separate zinc supplement, you could be overshooting the mark. I had to check my own multivitamin's label twice to make sure I was not doubling up.

The pricing is where things get less comfortable. At roughly $30-35 per 45-day bottle, you are looking at around $240-280 per year. Compared to a generic lutein supplement at $10-15 for the same timeframe, it is a significant premium. The question is whether that premium buys you anything — and for the AREDS2 formula specifically, the answer is that it buys you the exact studied formulation rather than a near-miss approximation.

Who Should Buy It?

Let me be direct about who this is actually for:

• Adults diagnosed with intermediate AMD — this is the primary group studied in AREDS2, and the one most strongly recommended by the NEI to take this formula
• Anyone with advanced AMD in one eye — the formula showed the most benefit in slowing AMD progression to both eyes
• Adults over 60 with a family history of macular degeneration who want proactive nutritional support after discussing it with their ophthalmologist
• People already taking the original AREDS formula who want to upgrade to the improved AREDS2 formula (which removed beta-carotene and added lutein and zeaxanthin)

Skip this if you have early-stage AMD with no symptoms, no family history, and no diagnosed eye condition — the evidence for preventive use in healthy adults is not established. Also skip it if you are a smoker or former smoker; the original AREDS formula contained beta-carotene which was linked to increased lung cancer risk in smokers (AREDS2 removed it, but many older PreserVision bottles still in circulation contain it). Check the label carefully.

Alternatives Worth Considering

• Generic Lutein + Zeaxanthin + Zinc supplements — significantly cheaper, but often with different dosage levels than the AREDS2 formula. Only worth considering if cost is a serious barrier and your doctor agrees the general nutrient profile is sufficient.
• EyePromise AREDS 2 — another AREDS2-based formula with some formulation variations and different capsule sizes. Some users prefer it for digestibility. Worth comparing if you tried PreserVision and had GI issues.
• MacuShield or MacuHealth — these use a different approach centered on meso-zeaxanthin in addition to lutein and zeaxanthin. The science here is less established than AREDS2 but some practitioners prefer this tri-carotenoid approach.

FAQ